Features
Get A Demo
Plans
Sign Up
Login
All Federal Contract IDV Awards
Help
Indefinite Delivery Contract SPE2DX15D9312
Award Date
4/27/15
Last Date to Order
12/31/25
Overview
🤔 AI Insights
Buyer Personas
Industry Personas
Buyer Personas In this Market
13
Activity
Contract IDVs
Contract Awards
1.6K
Transactions
1
Price Lists
Opportunity Stack
Federal Agency
Medical Supply Chain
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
SPE2DX15D9312
Indefinite Delivery Contract
1.6K
Federal Contract Awards
Description
Update #1
4600077794 ! TRICARE WEST
Posted 4/27/15, 12:00 AM
Mod #
Description
Reason For Modification
Federal Obligation
(Click to sort descending)
Date
(Click to sort ascending)
Not listed
4600077794 ! TRICARE WEST
Not listed
$0
4/27/15
Name
Description
Awardee
Potential Value
(Click to sort descending)
Award Date
(Click to sort descending)
Completion Date
(Click to sort descending)
Updated At
(Click to sort descending)
Delivery Order SPE2DX15D9312-SPE2DX21FDEKJ
4553449708 ! TRICARE WEST
DMS Pharmaceutical Group Inc.
$19.4k
4/30/21
5/21/21
4/30/21
Delivery Order SPE2DX15D9312-SPE2DX20FDEKZ
4550402857 ! TRICARE WEST
DMS Pharmaceutical Group Inc.
$35.0k
7/7/20
7/28/20
7/7/20
Delivery Order SPE2DX15D9312-B160
4536322039 ! TRICARE WEST
DMS Pharmaceutical Group Inc.
$204
12/1/16
12/2/16
12/1/16
Delivery Order SPE2DX15D9312-SPE2DX25FDEBE
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,153.80 contract is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of November 14, 2024. DMS Pharmaceutical Group Inc. also holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a wide range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This contract award is not associated with a specific set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal contracts across multiple product categories and medical domains.
DMS Pharmaceutical Group Inc.
$6.2k
10/23/24
11/14/24
10/23/24
Delivery Order SPE2DX15D9312-SPE2DX22FDEBE
4555232950 ! COLESTIPOL HCL GRANULES PACKET 30S
DMS Pharmaceutical Group Inc.
$188
10/19/21
10/20/21
10/19/21